Andrea Miuli
Overview
Explore the profile of Andrea Miuli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
287
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mosca A, Chiappini S, Mancusi G, Miuli A, Marrangone C, Allegretti R, et al.
Curr Neuropharmacol
. 2025 Feb;
PMID: 39976040
Background: The widespread availability and accessibility of over-the-counter (OTC) medicines play a vital role in modern healthcare systems, enabling individuals to manage minor health concerns independently. However, certain OTC medications...
2.
Lupi M, Chiappini S, Mosca A, Miuli A, Di Muzio I, Marrangone C, et al.
Actas Esp Psiquiatr
. 2025 Jan;
53(1):165-180.
PMID: 39801408
Background: Alcohol Use Disorders (AUD), affective disorders, and personality disorders are among the most prevalent mental health conditions observed in individuals exhibiting suicidal behavior, encompassing both completed and attempted suicides....
3.
Chiappini S, Gramuglia P, Mosca A, Cavallotto C, Miuli A, Corkery J, et al.
Front Psychiatry
. 2024 Dec;
15:1508732.
PMID: 39624511
Background: Methylphenidate (MPH), a central nervous system stimulant primarily prescribed for attention-deficit/hyperactivity disorder (ADHD), has seen increasing rates of misuse and abuse, particularly in patients with dual diagnosis (co-occurring psychiatric...
4.
Montemitro C, Mosca A, Chiappini S, Miuli A, Schifano F, Montano M, et al.
Pharmaceuticals (Basel)
. 2024 Oct;
17(10).
PMID: 39459026
Background: illegal drugs significantly contribute to global health issues, with health complications often occurring not only in regular users with Substance Use Disorders (SUDs) but also in first-time and occasional...
5.
Santorelli M, Miuli A, Pettorruso M, Di Carlo F, de Berardis D, Sensi S, et al.
Curr Neuropharmacol
. 2024 Oct;
PMID: 39449332
Background: Co-occurrence of substance use disorders is frequent in patients with mental health disorders is a condition known as "dual diagnosis". The use of substances worsens the prognosis and lowers...
6.
dAndrea G, Miuli A, Pettorruso M, Cavallotto C, Marrangone C, Cocco A, et al.
J Affect Disord
. 2024 Sep;
367:583-588.
PMID: 39233241
Background: Treatment-Resistant Depression (TRD) affects almost 30 % of patients with Major Depressive Disorder (MDD). Esketamine Nasal Spray (ESK-NS) has recently been approved for TRD in combination with a Serotonin...
7.
Mancusi G, Miuli A, Santorelli M, Cavallotto C, Susini O, Pernaci G, et al.
Behav Brain Res
. 2024 May;
469:115046.
PMID: 38761859
Background: This systematic review aims to comprehensively explore the impact of psychostimulant substances on neurotrophic and inflammatory pathways, including brain-derived neurotrophic factor (BDNF), pro-BDNF, cortisol, dehydroepiandrosterone sulfate (DHEAS), thiobarbituric acid...
8.
Chiappini S, Vaccaro G, Mosca A, Miuli A, Stigliano G, Stefanelli G, et al.
Neurosci Biobehav Rev
. 2024 May;
162():105691.
PMID: 38733894
The article presents a systematic literature review on the use and the psychiatric implications of over-the-counter drugs (OTC), prescription-only-medications (POM), and new psychoactive substances (NPS) within custodial settings. The searches...
9.
Pettorruso M, Miuli A, Clemente K, Mancusi G, Migliara G, Di Carlo F, et al.
Mol Psychiatry
. 2024 Jan;
29(3):760-766.
PMID: 38177347
Brain-derived neurotrophic factor (BDNF) and its precursor, proBDNF, are known to significantly contribute to brain homeostasis, neuroplasticity, and neuronal remodeling. Although these neurotrophins are thought to have opposing roles, both...
10.
Pettorruso M, dAndrea G, Di Carlo F, De Risio L, Zoratto F, Miuli A, et al.
Brain Stimul
. 2023 Sep;
16(5):1361.
PMID: 37716051
No abstract available.